Triple negative (TN) subtype (ER-negative and PR-negative and HER2-negative) accounts for 12.2% of breast cancers, and, among women diagnosed under age 50 years, the incidence is highest among African American and Hispanic women. This evidence concerns the gene ERBB2 and breast cancer.